Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

1. Balaña, C.
2. López-Pousa, A.
3. Berrocal, A.
4. Yaya-Tur, R.
5. Herrero, A.
6. García, J.-L.
7. Martín-Broto, J.
8. Benavides, M.
9. Cerdá-Nicolás, M.
10. Ballester, R.
11. Balart, J.
12. Capellades, J.